Grants and Contributions:
Title:
Development of oligomeric forms of prion-like proteins.
Agreement Number:
948559
Agreement Value:
$227,000.00
Agreement Date:
May 1, 2020 - Oct 29, 2021
Description:
This project will develop techniques to generate active, soluble oligomeric constructs of prion-like proteins relevant in neurological disease, including Tau, alpha synuclein and Abeta, using a variety of physical and chemical techniques.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Victoria, British Columbia, CA V8T 2C1
Reference Number:
172-2020-2021-Q1-948559
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
838513760
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The total amended value is 37,000 dollars.
Amendment Date
Dec 3, 2020
Recipient's Legal Name:
StressMarq Biosciences Inc.
Federal Riding Name:
Victoria
Federal Riding Number:
59041
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
32519
Amendments: